Ireland
--:--IST
Recruiting Not applicable

Effectiveness of Thoracoabdominal Nerve Block (M-TAPA) on Postoperative Pain Relief in Laparoscopic Hysterectomy

NCT07483190 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-06-09
Last updated
2026-06-16

Condition(s) studied

Postoperative PainHysterectomyPlane Blocks

Investigational drug(s) / intervention(s)

Modified-Thoracoabdominal Nerve Block through a Perichondrial Approach (M-TAPA)

Modified-Thoracoabdominal Nerve Block through a Perichondrial Approach (M-TAPA): Under ultrasound guidance, a 22-gauge peripheral block needle is inserted at the costochondral angle (9th-10th ribs). After confirming the position, 20 ml of 0.25% bupivacaine is injected bilaterally into the lower part of the chondrium.

Study summary

This study aims to investigate the effectiveness of a specific regional anesthesia technique, the Modified-Thoracoabdominal Nerve Block through a Perichondrial Approach (M-TAPA), on reducing pain after laparoscopic hysterectomy surgery. Hysterectomy is a common major surgical procedure, and managing postoperative pain is crucial for patient comfort and faster recovery.

Participants will be randomly assigned to one of two groups:

The M-TAPA Group: Patients will receive the nerve block using a local anesthetic (bupivacaine) before the surgery begins.

The Control Group: Patients will receive standard postoperative pain management without the nerve block.

The primary goal is to determine if the M-TAPA block reduces the total amount of opioid (morphine) used by patients in the first 24 hours after surgery. The researchers will also evaluate pain scores (NRS), the time until the first request for additional pain medication, patient satisfaction, and any side effects like nausea or vomiting

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Aged between 18 and 70 years * ASA (American Society of Anesthesiologists) physical status I, II, or III * Scheduled for elective laparoscopic hysterectomy * Voluntary participation with signed informed consent Exclusion Criteria: * Hepatic or renal disease. * Coagulation disorders. * Uncontrolled cardiovascular or respiratory diseases. * Psychiatric disorders. * History of allergy to local anesthetics. * History of alcoholism, drug or substance abuse. * Body Mass Index (BMI) greater than 35 kg/m2 * Refusal of the regional block procedure

Primary outcome measure(s)

  • Morphine consumption — First 24 hours postoperatively
    Total amount of morphine (mg) used via Patient-Controlled Analgesia (PCA)

Trial sites (1)

FacilityCityRegionStatus
Istinye University Liv Hospital Bahcesehir Istanbul Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07483190 on ClinicalTrials.gov ↗ ← All trials in Turkey